Search Results

You are looking at 1 - 2 of 2 items for

  • Author or Editor: Susan C. Randell x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objective—To determine whether mild restriction of food intake affects clinicopathologic variables, body composition, and performance of dogs undertaking intense sprint exercise.

Animals—9 trained healthy adult Greyhounds.

Procedure—Dogs were offered food free choice once daily for 9 weeks until body weight and food intake stabilized. Dogs were then randomly assigned to be fed either 85% or 100% of this quantity of food in a crossover study (duration of each diet treatment period, 9 weeks). Dogs raced a distance of 500 m twice weekly. Clinicopathologic variables were assessed before and 5 minutes after racing; food intake, weight, body composition, body condition score, and race times were compared at the end of each diet period.

Results—Compared with values associated with unrestricted access to food, there were significant decreases in mean body weight (by 6%) and median body condition score (from 3.75 to 3.5 on a 9-point scale) and the mean speed of the dogs was significantly faster (by 0.7 km/h) when food intake was restricted. Body composition and most clinicopathologic variables were unaffected by diet treatment, but dogs given restricted access to food had slightly fewer neutrophils, compared with values determined when food intake was unrestricted.

Conclusions and Clinical Relevance—Results indicate that the common practice among Greyhound trainers of mildly restricting food intake of racing dogs to reduce body weight does improve sprint performance. A body condition score of approximately 3.5 on a 9-point scale is normal for a trained Greyhound in racing condition. (Am J Vet Res 2005;66:1065–1070)

Full access
in American Journal of Veterinary Research

Abstract

Objective—To determine whether plasma concentrations of benzodiazepines (BDZ) in dogs following intranasal (IN) administration of diazepam are comparable to concentrations following IV administration.

Animals—6 (4 male, 2 female) healthy adult Greyhounds.

Procedure—Dogs were randomly assigned to 2 groups of 3 dogs in a crossover design. Diazepam (0.5 mg/kg of body weight) was administered intravenously to dogs in group 1 and intranasally to dogs in group 2. Blood was collected from the jugular vein of each dog into tubes containing lithium heparin before and 3, 6, 9, 12, 15, 20, 30, 60, 120, 240, and 480 minutes following diazepam administration. After a 4-day washout period, dogs in group 1 received diazepam intranasally, dogs in group 2 received diazepam intravenously, and blood was again collected. Plasma concentration of BDZ was determined by use of a fluorescence polarization immunoassay.

Results—Mean (± SD) peak plasma concentration of BDZ following IV administration (1316 ± 216 µg/L) was greater than that following IN administration (448 ± 41 µg/L). Time to peak concentration was ≤ 3 minutes following IV administration and 4.5 ± 1.5 minutes following IN administration. Mean bioavailability of BDZ following IN administration was 80 ± 9%.

Conclusions and Clinical Relevance—Diazepam is rapidly and efficiently absorbed following IN administration of the parenteral formulation. Plasma concentrations match or exceed the suggested therapeutic concentration (300 µg/L). Intranasal administration of diazepam may be useful for treatment of seizures in dogs by owners or when intravenous access is not readily available. (Am J Vet Res 2000;61:651–654)

Full access
in American Journal of Veterinary Research